What changed
$WELL — Decentralized health data marketplace for patients.
🎯 Q1 FY26 | Rev $3B | EPS $1.02 vs $0.72 🟢
💡 Consensus expects FY2026 EPS of $2.97, but management just raised guidance to $3.24-$3.38. The market is pricing in a deceleration in FFO growth despite strong Q1 beat (EPS $1.02 vs $0.72) and accelerating revenue (+38% YoY).
🏢 Business Quality: 8/10 | Valuation: fair
📉 Reward/Risk: Upside 15% to $244 (18x forward FFO) vs downside 10% to $191 (16x forward FFO) = 1.5:1 ratio.
🔮 Catalyst: Q2 2026 earnings (early Aug 2026): consensus EPS $0.665, but momentum suggests upside to $0.75+. Key metric: same-store NOI growth (target >4%). Failure signal: occupancy drops below 94% or guidance cut.
💰 Entry: Current price $212 is attractive within fair value range. Ideal entry $200-$205 (3-5% downside). Consider adding on any pullback to $200.
Also in play: $CNC $HUM $UNH $CI $MOH $MCK